| Product Name | MF | CAS | Details |
|---|
| (3-methylisoxazol-5-yl)methylamine | C5H9ClN2O | 70183-89-0 | Details |
| CD4 protein (His tag) | Details |
| Gatifloxacin hydrate | C19H24FN3O5 | 614751-80-3 | Details |
| 5-Bromo-3-methyl-2-(1H-pyrazol-1-yl)pyridine hydrochloride | C9H9BrClN3 | 1909318-97-3 | Details |
| Sontuzumab | 372075-37-1 | Details |
| p38 antibody | Details |
| TRIM55 antibody | Details |
| Hepta-O-acetyl-b-Lactosyl-N-Fmoc-L-threonine | C45H53NO22 | 657395-98-7 | Details |
| Ile-Val-Tyr-Arg-Asp-Gly-Asn-Pro-Tyr-Ala | Details |
| QAPGQGLEWMGDINTR* - SIL Emicizumab? signature peptide qualifier | Details |
| Validamine acetate | 929880-73-9 | Details |
| 4-Isothiocyanatophenyl-alpha-D-mannopyranoside | C13H15NO6S | 96345-79-8 | Details |
| 2-Amino-5-(trifluoromethoxy)phenol hydrochloride | C7H7ClF3NO2 | 1803591-35-6 | Details |
| Methyl 2,5-dihydroxybenzoate | C8H8O4 | 2150-46-1 | Details |
| 14 3 3 theta antibody | Details |
| 2-(5-bromopyridin-3-yl)propan-2-ol | C8H10BrNO | 40472-88-6 | Details |
| 4,6-Dimethyl-N-phenylpyrimidin-2-amine | C12H13N3 | 53112-28-0 | Details |
| Thrombin?Substrate?II | Details |
| Canadine | C20H21NO4 | 522-97-4 | Details |
| Dolutegravir intermediate-1 | C13H17NO8 | 1335210-23-5 | Details |
| 2-Amino-5-propylbenzoic acid | C10H13NO2 | 637347-93-4 | Details |
| methyl 2-fluoro-3-formylbenzoate | C9H7FO3 | 1262419-96-4 | Details |
| Myxovirus Blocking Peptide | Details |
| GSK690693 | C21H27N7O3 | 937174-76-0 | Details |
| Isoarundinin II | C22H22O4 | 151538-56-6 | Details |
| D-Gulose | C6H12O6 | 4205-23-6 | Details |
| 1-(1H-Indazole-5-carbonyl)piperidine-4-carboxylic acid | C14H15N3O3 | 1099083-58-5 | Details |
| 4-bromo-2-fluoropyridine-3-carboxylic acid | C6H3BrFNO2 | 1256790-84-7 | Details |
| m-dPEG?37-acid | (C2H4O)nC3H6O3 | 117786-94-4 | Details |
| 3-(2-Methyl-1,4-oxazepan-4-yl)propan-1-amine | C9H20N2O | 1341990-48-4 | Details |
| 2-Chloro-N-(1,1-dioxo-tetrahydro-1lambda(6)-thiophen-3-yl)-N-methyl-acetamide | C7H12ClNO3S | 7365-23-3 | Details |
| Prolactin-Releasing Peptide (1-31) (human) | C160H252N56O42S | 215510-22-8 | Details |
| Spike S protein library | Details |
| Stigmasteryl tosylate | C36H54O3S | 53139-42-7 | Details |
| 2-(Isothiocyanatomethyl)oxane | C7H11NOS | 50450-56-1 | Details |
| (1S) -1- [(2S, 3S,4R) -4-Hydroxymethyl-3- hydroxy-1- azetidinyl] -1, 2- ethanediol hydrochloride | Details |
| SIRT5 antibody | Details |
| CPEB1 protein (His tag) | Details |
| HXB2 gag NO-18 | C70H114N20O27 | Details |
| (3R,?4S)?-?rel-4-?Chlorotetrahydro-?3-?thiophenamine 1,?1-?dioxide hydrochloride | C4H9Cl2NO2S | 114145-47-0 | Details |
| tert-Butyl N-({[(dimethylamino)methylidene]amino}methanimidoyl)carbamate | 2248418-52-0 | Details |
| 1-{[(tert-Butoxy)carbonyl](cyclopropyl)amino}cyclobutane-1-carboxylic acid | C13H21NO4 | 1490273-29-4 | Details |
| rac Bendroflumethiazide | C15H14F3N3O4S2 | 73-48-3 | Details |
| 3-Methyl-2-phenoxybutanoic acid | C11H14O3 | 13794-02-0 | Details |
| Vasicine | C11H12N2O | 6159-55-3 | Details |
| 3-Chloro-2-(pyridin-3-yloxy)aniline | C11H9ClN2O | 869945-98-2 | Details |
| Sitagliptin hydroxy amide impurity | C16H14F6N4O2 | 1253056-01-7 | Details |
| 3-Cyclopentylbenzoic acid | C12H14O2 | 19920-79-7 | Details |
| 2-Chloroquinoline | C9H6ClN | 612-62-4 | Details |
| 1-(4-Acetylthiophen-2-yl)-2-chloroethan-1-one | C8H7ClO2S | 556110-53-3 | Details |
| α-Glucosidase from bacillus stearothermophilus, lyophilized powder, 300000U/g | NULL | 9001-42-7 | Details |
| GLYATL2 protein (His tag) | Details |
| SB 616234-A | C32H36ClN5O3 | 980601-49-0 | Details |
| 5-Chloro-2-nitrodiphenylamine | C12H9ClN2O2 | 25781-92-4 | Details |
| tert-Butyl 3-(5-amino-1-methyl-1H-1,2,4-triazol-3-yl)piperidine-1-carboxylate | C13H23N5O2 | 2228305-67-5 | Details |
| 3-(4-Bromo-2-fluorophenyl)pentanedioic acid | C11H10BrFO4 | 1814293-88-3 | Details |
| 3-Hydroxy carbamazepine | C15H12N2O2 | 68011-67-6 | Details |
| 2-Chloro-1-methylpyridinium | 45528-84-5 | Details |
| PF-06260414 | C14H14N4O2S | 1612755-71-1 | Details |
| 2,4-dichloro-8-methoxyquinoline | C10H7Cl2NO | 32608-29-0 | Details |
| (6-Bromo-1-methyl-1H-1,3-benzodiazol-2-yl)methanol | C9H9BrN2O | 958863-32-6 | Details |
| 3-Oxo-1-methylquinuclidinium iodide | C8H14NO.I | 6659-51-4 | Details |
| LMF2 Blocking Peptide | Details |
| CDC42EP4 Blocking Peptide | Details |
| 4-Bromo-2-methyl-1-vinylbenzene | C9H9Br | 943741-00-2 | Details |
| Ethyl 3-bromo-4-oxopentanoate | C7H11BrO3 | 54260-84-3 | Details |
| 7-Methyl-1-benzofuran-3-carboxylic acid | C10H8O3 | 1033196-18-7 | Details |
| 6,7-Difluoro-3,4-dihydro-2H-1,4-benzoxazin-3-one | C8H5F2NO2 | 865106-46-3 | Details |
| (2E)-N-(2-Hydroxyethyl)-3-phenylprop-2-enamide | C11H13NO2 | 35241-61-3 | Details |
| Human APRIL ELISA kit | Details |
| 5,8-Difluoro-3,4-dihydro-2H-1,4-benzoxazine hydrochloride | 1955522-63-0 | Details |
| 1-Methyl-3-(1-methyl-1H-pyrazol-5-yl)-1H-pyrazole-4-carbaldehyde | C9H10N4O | 1694299-08-5 | Details |
| 4-Chloro-5-(2-((3-hydroxyphenyl)methylidene)hydrazin-1-yl)-2,3-dihydropyridazin-3-one | C11H9ClN4O2 | 92285-87-5 | Details |
| 2-[2-(2-Hydroxyethyl)phenyl]ethan-1-ol | C10H14O2 | 17378-99-3 | Details |
| H-IYDSTTFR-OH | Details |
| Decumbenine C | C19H11NO6 | 100163-16-4 | Details |
| 2-Benzyltryptamine | C17H18N2 | 22294-23-1 | Details |
| 1-(5-Chlorothiophen-2-yl)propan-2-ol | C7H9ClOS | 1250362-69-6 | Details |
| Pseudomonas aeruginosa serotype 6c Ab | Details |
| WDR1 Blocking Peptide | Details |
| 1,3-Dioxo-2,3-dihydro-1H-isoindol-2-yl prop-2-enoate | C11H7NO4 | 55484-53-2 | Details |
| (2,3-bis(4-methoxyphenyl)-1-oxo(4-2,3,4-trihydroisoquinolyl))-N-(4-pyridylmethyl)formamide | C30H27N3O4 | 1023029-69-7 | Details |
| 6-Chloro-3-methyl-3,4-dihydro-2H-1-benzothiopyran-4-one | C10H9ClOS | 199783-62-5 | Details |
| MOB3B protein (His tag) | Details |
| N-(4-Amino-2-methylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide | C13H17N3O2 | 953900-28-2 | Details |
| 2-[(4-Aminophenyl)methyl]butanoic acid | C11H15NO2 | 103893-69-2 | Details |
| 2,3,5,6-Tetrachlorobenzoic acid | C7H2Cl4O2 | 50-38-4 | Details |
| 2-amino-1-aza-2-(4-(5-(trifluoromethyl)(2-pyridyloxy))phenyl)vinyl pyridine-3-carboxylate | C19H13F3N4O3 | 1025653-41-1 | Details |
| 5,5-Difluoropentan-2-amine hydrochloride | C5H12ClF2N | 2060033-86-3 | Details |
| (1-ethynylcyclopropyl)benzene | C11H10 | 139633-98-0 | Details |
| 3-Methyl-2-hydroxy-3H-imidazo[4,5-f]quinoline | C11H9N3O | 144486-08-8 | Details |
| CEP41 antibody | Details |
| JH-RE-06 | C20H16Cl3N3O4 | 1361227-90-8 | Details |
| 2-(4-Aminophenyl)-6-methoxybenzothiazole | C14H12N2OS | 43036-17-5 | Details |
| 4-(2-Methoxyethyl)-5-(2-phenylethyl)-4H-1,2,4-triazole-3-thiol | C13H17N3OS | 663181-86-0 | Details |
| EMG1 protein (His tag) | Details |
| 6-Fluoro-2-methyl-2,3-dihydro-1-benzofuran-3-amine hydrochloride | C9H11ClFNO | 1803587-48-5 | Details |
| N,N-Diethyl-4-(4-formyl-2-methoxy-phenoxy)-3-nitro-benzenesulfonamide | C18H20N2O7S | 556020-33-8 | Details |
| 3-(methoxycarbonyl)-4-methylbenzoic acid | C10H10O4 | 167300-06-3 | Details |
| Rabbit anti Mouse IgG1 (FITC) | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||